Heron Therapeutics
HRTX
#7834
Rank
S$0.32 B
Marketcap
$2.14
Share price
3.27%
Change (1 day)
-9.78%
Change (1 year)

Heron Therapeutics (HRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$0.35 Billion

According to Heron Therapeutics's latest financial reports the company's total liabilities are S$0.35 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Heron Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.33 B6.44%
2022-12-31S$0.31 B3.18%
2021-12-31S$0.30 B99.15%
2020-12-31S$0.15 B5.44%
2019-12-31S$0.14 B16.84%
2018-12-31S$0.12 B-8.9%
2017-12-31S$0.13 B7.45%
2016-12-31S$0.12 B360.04%
2015-12-31S$27.91 M55.12%
2014-12-31S$17.99 M103.15%
2013-12-31S$8.85 M74.39%
2012-12-31S$5.07 M6.22%
2011-12-31S$4.78 M132.78%
2010-12-31S$2.05 M-32.09%
2009-12-31S$3.02 M-49.65%
2008-12-31S$6 M-44.14%
2007-12-31S$10.75 M35.13%
2006-12-31S$7.96 M72.87%
2005-12-31S$4.6 M-1.29%
2004-12-31S$4.66 M45.15%
2003-12-31S$3.21 M-20.22%
2002-12-31S$4.02 M-49.79%
2001-12-31S$8.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$1.16 B 231.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$1.04 B 196.07%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.35 B-0.65%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.15 B-56.40%๐Ÿ‡บ๐Ÿ‡ธ USA
S$80.8 M-77.12%๐Ÿ‡บ๐Ÿ‡ธ USA